The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 12, 1997, Pages 3926-3929

  Girgis, Rose ^a   Winter, Jeremy S D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE GROWTH; BONE MATURATION; BONE MINERAL; BONE TURNOVER; CHILD; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; HYPERCORTISOLISM; MALE; PRIORITY JOURNAL;

EID: 0030867096     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.12.4320     Document Type: Article

References (16)

1. Winter JSD, Couch RM. 1985 Modern medical therapy of congenital adrenal hyperplasia: a decade of experience. Ann NY Acad Sci. 458:165-173.
2. Jääskiläinen J, Voutilainen R. 1997 Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr Res. 41:30-33.
3. Yu ACM, Grant DB. 1995 Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood. Acta Pediatr. 84:899-903.
4. Di Martino-Nardi J, Stoner E, O'Connell A, New MI. 1986 The effect of treatment on final height in classical congenital adrenal hyperplasia treated with hydrocortisone. Acta Endocrinol (Copenh). 279 (Suppl):305-314.
5. Van Wyk JJ, Gunther DF, Ritzén EM, et al. 1996 Therapeutic controversies: the use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 81:3180-3190.
6. Kehlet H, Binder C, Blichert-Toft M. 1976 Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clin Endocrinol (Oxf). 5:37-41.
7. Greulich WW, Pyle SI. 1959: Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford, CA: Stanford University Press.
8. Faulkner RA, Bailey DA, Drinkwater DT, Wilkinson AA, Houston CS, McKay HA. 1993 Regional and total body bone mineral content, bone mineral density, and total body tissue composition in children 8-16 years of age. Calcif Tissue Int. 53:7-12.
9. Del Rio L, Carascosa A, Pons F, Gusinye M, Yeste D, Domenech FM. 1994 Bone mineral density of the lumbar spine in white mediterranean Spanish children and adolescents: changes related to age, sex, and puberty. Pediatr Res. 35:362-366.
10. Magnusson P, Häger A, Larsson L. 1995 Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents. Pediatr Res. 38:955-961.
11. Tarallo P, Henny J, Fournier B, Siest G. 1990 Plasma osteocalcin: biological variations and reference limits. Scand J Clin Lab Invest. 50:649-655.
12. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Dinero G. 1994 Twenty-four hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth retarded children. Pediatr Res. 35:409-415.
13. Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. 1992 A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 7:1251-1258.
14. Norusis MJ. 1993 SPSS for Windows: Advanced Statistics Release 6.0. SPSS Inc.
15. Winter RM, Klingensmith GJ. 1977 Congenital adrenal hyperplasia mortality experience. In: Lee PA, Plotnick LP, Kowarski AA, Migeon CJ, eds. Congenital adrenal hyperplasia. Baltimore: University Park Press; 339-334.
16. Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD. 1995 Bone mineral density and body composition in congenital adrenal hyperplasia. J Clin Endocrinol Metab. 80:2238-2243.